Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
An analysis of a previous study of a tenofovir-based vaginal gel found that women with vaginal inflammation were less protected.
Accelerating the response to the global HIV epidemic requires targeting key affected populations and tailoring efforts around geographic parti...
Researchers have mapped the development of a key HIV antibody, establishing scientific knowhow that may aid in the development of a vaccine.
The panel is chaired by professor Salim S. Abdool Karim.
A new discovery could prove a major stepping-stone toward developing an effective HIV vaccine. In South Africa, two women’s immune systems rea...
HIV prevention efforts have suffered a major setback following a Microbicide Trials Network (MTN) announcement that a vaginal gel containing t...
Rectal microbicides-topical gels, ointments and lubricants laced with drugs to block HIV-could help stop the spread of the virus. So why...
U.S. women involved in a study comparing the safety, blood levels and acceptability of two methods of pre-exposure prophylaxis (PrEP) to preve...
Microbicide researchers announced success with a new rectal gel designed to cut HIV transmission
The first of a two-part look at the top treatment news of 2010.
After decades of research, a microbicidal gel—in this case made from the antiretroviral drug tenofovir—has finally proved effectiv...
Test trial looks to see if vaginal gels, films and contraceptive-style rings made with an antiretroviral medication will be effective.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.